Latest in Cardiology from ACC.org

• ACC CardiaCast: PulseCheck: Palliative Care in Patients with Heart Disease: High-Risk Procedures in Our High-Risk Patients
  In this episode, Andrea Price, MS, AACC hosts Richard A. Josephson, MS, MD, FACC, Christy Cantey DNP, FNP-C, AACC, CCK, and Gwen M. Bernacki, MD MHSA to share insights for high-risk procedures in our high risk patients: we can, but should we?
• ACC Practice Made Perfect: Reducing Burnout Through AI Integration
  In this second episode in a three-part series of episodes focusing on artificial intelligence (AI) in cardiology, Dr. Effie Andrikopoulou hosts Dr. Nishath Quader and Mr. Demetri Giannikopoulos to discover how innovative AI solutions can tackle one of the biggest challenges facing today’s cardiologists—burnout.
• Rivaroxaban Beyond 6 Weeks: Enhancing Outcomes in Isolated Distal Deep Vein Thrombosis
  The optimal management of isolated, distal deep vein thrombosis (DVT) remains unclear. Data from recent studies suggest that certain patients may benefit from anticoagulation...
• Pregnancy in Adult Congenital Heart Disease
  The prevalence of congenital heart disease (CHD) in pregnancy increased by >30% during the 2010s. CHD is now present in approximately 8:10,000 pregnant persons.
• ACCEL Lite: SUMMIT Trial: Tirzepatide for Heart Failure, Preserved Ejection Fraction and Obesity
  In this interview, Drs. Alison Bailey and Milton Packer examine the power of tirzepatide expanding beyond weight loss and treating diabetes in addition to reducing heart failure events in patients with obesity-related HFpEF.